Wednesday, June 10, 2026
🇺🇸 FDA

biotech · Breast Cancer · Pleural carcinosis · SANA

Sana Biotechnology

Sana Biotechnology patent portfolio — 136 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
188 E Blaine St, Suite 400, Seattle, Washington 98102, US HQ
2018 Founded
265 Employees
Public company Type
SANA · NYSE Ticker
Company details
Status
Public
HQ
188 E Blaine St, Suite 400, Seattle, Washington 98102, US
Founded
2018
Employees
265
Programs
19
Drugs
21
Patents
136
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Sana Biotechnology patents

136 pharmaceutical patents indexed for Sana Biotechnology. 2 expire within 24 months.

Sana Biotechnology has 136 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

136 patents

Patent portfolio

Page 3 of 3

  1. US 9145411

    Substituted amino-pyrimidine derivatives

    Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9114085

    Modified release pharmaceutical compositions of dexlansoprazole

    Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9115092

    Substituted quinazoline and pyrido-pyrimidine derivatives

    Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9095515

    Ezetimibe compositions

    Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9044482

    Use of aminoindane compounds in treating overactive bladder and interstitial cystitis

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9023322

    Chewing gum compositions comprising cannabinoids

    Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8992944

    Purified Plasmodium and vaccine composition

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8952153

    One pot process for preparing pemetrexed disodium

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8906949

    Orally disintegrating tablets of zolmitriptan and process for preparing the same

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8865741

    Aminoindane compounds and use thereof in treating pain

    Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8821896

    Purified Plasmodium and vaccine composition

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8821850

    Protein-polymer-drug conjugates

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8815226

    Protein-polymer-drug conjugates

    Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8808679

    Auristatin compounds and conjugates thereof

    Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8809372

    Pyridine derivatives

    Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8778391

    Flurbiprofen and muscle relaxant combinations

    Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8758818

    Oral tablet compositions of dexlansoprazole

    Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8753682

    Dual release oral tablet compositions of dexlansoprazole

    Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8741345

    Modified release pharmaceutical compositions of dexlansoprazole

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8691778

    Flurbiprofen and muscle relaxant gel combinations thereof

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8685383

    Protein-polymer-drug conjugates

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8680319

    Method for producing antifolate agents having glutamic acid part in their structure

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8563035

    Oral tablet compositions of dexlansoprazole

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8563034

    Dual release oral tablet compositions of dexlansoprazole

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8524214

    Polyal drug conjugates comprising variable rate-releasing linkers

    Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8512746

    Extended release pharmaceutical compositions of levetiracetam

    Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8491880

    Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugates

    Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8399512

    Biocompatible biodegradable fumagillin analog conjugates

    Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8367810

    Purified plasmodium and vaccine compositions

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8349308

    Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8323670

    Topical compositions of opioid antagonists and methods for treating skin conditions therewith

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8314122

    Using of organic solvents in wet granulation of moxifloxacin

    Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8252926

    Process for the preparation of imatinib base

    Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8043625

    Purified plasmodium and vaccine compositions

    Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7923042

    Medicated gauze

    Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7651701

    Bone cement composition and method of making the same

    Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7229627

    Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production

    Expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7214391

    Botanical extract compositions and process for preparing same

    Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 6361803

    Antioxidant compositions extracted from a wastewater from olive oil production

    Expires Mon Mar 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6358542

    Antioxidant compositions extracted from olives and olive by-products

    Expires Mon Mar 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Sana Biotechnology have?

136 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Sana Biotechnology patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.